New Zealand markets close in 2 hours 47 minutes

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.49-0.28 (-2.19%)
At close: 04:00PM EDT
12.65 +0.16 (+1.28%)
After hours: 05:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
142,903
130,521
85,618
43,584
9,100
-
Selling general and administrative
84,073
75,543
61,291
29,159
4,682
-
Total operating expenses
226,976
206,064
146,909
72,743
13,782
-
Operating income or loss
-226,976
-206,064
-146,909
-72,743
-13,782
-
Interest expense
-
-
-
-
30
2,077
Total other income/expenses net
18,040
17,147
4,728
-11
-30,031
-
Income before tax
-208,936
-188,917
-142,181
-72,754
-43,843
-
Income from continuing operations
-208,936
-188,917
-142,181
-72,754
-43,843
-
Net income
-208,936
-188,917
-142,181
-70,645
-40,507
-
Net income available to common shareholders
-208,936
-188,917
-142,181
-170,639
-40,507
-
Basic EPS
-2.29
-
-2.17
-4.62
-0.96
-0.30
Diluted EPS
-2.29
-
-2.17
-4.62
-0.96
-0.30
Basic average shares
76,086
-
65,467
36,961
42,031
42,031
Diluted average shares
76,086
-
65,467
36,961
42,031
42,031